NEW YORK CITY, NEW YORK / ACCESS Newswire / October 30, 2025 / TruMerit President and CEO Peter Preziosi has been elected ...

LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 30, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into ...

Physician-led wellness brand brings its evidence-based longevity and recovery model to downtown LA. LOS ANGELES, CA / ACCESS ...

In an era where chronic inflammatory diseases are taking centre stage in healthcare debates, the biologics segment is ...

Novo Nordisk has topped Pfizer’s offer for Metsera with a bid of up to US$9 billion, seeking to secure Metsera’s obesity-drug ...

Regeneron and ModeX Therapeutics have joined forces in a collaboration worth over one billion dollars to develop ...

Novartis will acquire Avidity Biosciences for about US$12 billion to gain its RNA platform and late-stage rare-disease ...

Medidata Consent, a key part of the Medidata Patient Experience, expedites study start-up, reduces configuration complexity, and improves patient enrollment New York – Oct. 30, 2025 – Medidata, a ...

Former Inizio Evoke President of CX joins Supreme Group’s management team to lead platform-wide growth strategy  WEST CHESTER, Pa. — Oct. 30, 2025 — Supreme Group, a next-generation agency platform ...

BOCA RATON, FL / ACCESS Newswire / October 30, 2025 / Entero Therapeutics (NASDAQ:ENTO) has just made one of the boldest moves in its history, a reinvention that trades long biotech timelines for ...

MESA, ARIZONA / ACCESS Newswire / October 30, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), a diversified holding company operating at the intersection of technology, wellness, and ...

ATLANTA, GA / ACCESS Newswire / October 30, 2025 / Dogwood Therapeutics, Inc. (Nasdaq:DWTX) (the "Company"), a development‐stage biotechnology company developing new medicines to treat pain and ...